From the Research
The recommended treatment for epilepsy in patients with frontotemporal dementia (FTD) is Levetiracetam (Keppra) or Lamotrigine (Lamictal), as they have minimal cognitive side effects and are effective in controlling seizures. When considering treatment options, it's crucial to prioritize medications that have fewer drug interactions and less impact on cognition compared to older AEDs.
- Levetiracetam can be started at 500mg twice daily and titrated up to 1500mg twice daily as needed for seizure control.
- Lamotrigine is another good option, starting at 25mg daily and slowly increasing to 100-200mg twice daily over several weeks to avoid rash development. Key considerations include:
- Avoiding medications like phenobarbital, phenytoin, and topiramate, which can worsen cognitive function in dementia patients 1.
- Individualizing treatment based on seizure type, frequency, comorbidities, and potential drug interactions with other medications the patient may be taking for FTD or other conditions. Regular monitoring of seizure frequency, medication side effects, and drug levels (when applicable) is essential, as epilepsy in FTD patients can accelerate cognitive decline if poorly controlled 2, 3, 4, 5.